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The risky womb and the unthinkability of the pregnant man: Addressing trans 
masculine hysterectomy 
Abstract 
In April 2017, the European Court of Human Rights ruled that requiring trans people 
to undergo sterilisation in order to grant legal gender recognition was a breach of 
human rights. In the UK, sterilisation has never been a legal requirement for trans 
people. However, hysterectomy and salpingo-oopherectomy have been strongly 
encouraged for trans masculine people on medical grounds, although the clinical 
evidence for current recommendations is weak. Within this article I analyse the issue 
from a feminist perspective and argue that current presumptions in favour of surgical 
intervention are influenced by the history of medical interventions to ‘fix’ bodies 
perceived as female, coupled with a strong social taboo against the pregnant man. 
As a consequence, medical and legal frameworks are not necessarily facilitating 
optimal outcomes for the individual. I suggest that practices in this regard should be 
critically examined, with a view to developing more tailored, person-centred practices 
and facilitating informed choice. 
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Background 
Trans masculine people are men or non-binary people who were originally assigned 
female at birth. Although some trans masculine people also have intersex conditions, 
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the majority will have been born with reproductive anatomy which is typically 
perceived as female, including a womb and ovaries. At present, many European 
countries require that trans people are sterilised prior to legal recognition (TGEU, 
2016). However, a ruling by the European Court of Human Rights in April 2017 
determined that this was incompatible with human rights ("Affaire A.P., Garcon et 
Nicot c. France," 2017). In the UK, the Gender Recognition Act (2004) does not 
create a legal requirement for sterilisation, but NHS England (2013) protocol 
recommends that trans masculine people who are taking testosterone should 
undergo hysterectomy and salpingo-oopherectomy within five years of commencing 
testosterone, even if they do not propose to have other masculinising surgeries  
Medical intervention for trans people has historically been subject to gatekeeping, 
with a strong focus upon establishing that those who seek medical intervention meet 
clinical thresholds (Bockting, Robinson, Benner, & Scheltema, 2004; Coleman, 2016; 
Singh & Burnes, 2010). There is a longstanding principle that more reversible 
interventions, such as social transition and hormone therapy, should be undertaken 
before irreversible interventions, such as surgery (Benjamin, 1966; Coleman et al., 
2012; Richards & Seal, 2014). Surgical intervention for trans people has therefore 
implicitly been treated as a ‘last resort’, only offered when there is no doubt that it is 
required. However, current UK practice regarding hysterectomies for trans masculine 
people taking testosterone deviates from these principles. For this population group, 
surgical intervention is treated as a preferred option, to be done “just in case” of a 
relatively unproven risk. Within this paper, I argue that this derives from three 
interlinked assumptions: that reproductive anatomy perceived as female inherently 
confers risk; that relatively little justification is needed to remove such anatomy; and 
that trans masculine people will not – or should not – become pregnant. I suggest 
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that this has implications as other jurisdictions in Europe move beyond legally-
mandated sterilisation. 
Feminism, the body and trans masculinity 
The medicalisation of the womb, fertility and childbirth are archetypal feminist 
discussions (Groneman, 1994; Rich, 1980; J.M. Ussher, 1991; Young, 2005). These 
debates raise questions about the ways in which bodies and organs that are socially 
coded as female are viewed within medical frameworks. Yet this creates a very 
immediate dilemma: the bodies I wish to discuss are bodies of men and non-binary 
people, which have organs typically seen as female. One potential solution to this 
dilemma would be to resort to the traditional sex/gender split, in which male and 
female are purely labels for certain types of body (Oakley, 1972). Then there would 
be no contradiction in talking about men or non-binary people having female bodies. 
However, this reifies binaristic essentialist divides between sex and gender and 
between male and female which I find largely unhelpful (Butler, 2004). More 
significantly, I consider it to be inauthentic to my own experiences and, I suspect, to 
the experiences of many other trans masculine people. Being trans may result in 
bodily experiences which cannot be easily mapped onto binary biological categories 
of ‘male’ and ‘female’: for example, physiological experiences which arise from 
having ‘male’ levels of testosterone in bodies with a womb and ovaries. Riggs (2013) 
suggest that trans masculine people’s self-representations typically seek to describe 
an embodied experience of pregnancy and parenthood, without being constrained by 
binaristic notions of ‘man’, ‘woman’, ‘father’ and ‘mother’. Rubin (2003) describes 
related difficulties in finding a way of paralleling some similarities between the 
experiences of trans men and gender non-conforming women, while also respecting 
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trans men’s embodied identities as men. Simply describing trans masculine people’s 
bodies as ‘female’ is unauthentic and for many, unacceptable. 
The difficulty of finding non-essentialist, trans-inclusive ways of talking about bodies 
and experiences is scarcely new for feminism. Stone’s (1991) ‘Posttranssexual 
manifesto’ is often presented as the starting point of modern transfeminist studies. 
Stone critiques the ways in which trans experience have been framed both by 
medical categorisation and pre-existing discourses of gender, and asserts the voice 
of trans people as active subjects. Paradoxical constraints are placed upon trans 
experiences: trans people are expected to perform gender in a way which meets 
medical and legislative requirements; yet simultaneously criticised for upholding 
gender norms (Butler, 2004; Serano, 2007; Spade, 2006; Stone, 1991)  Califia 
(1997) and Serano (2013) point out that the social scrutiny trans people are 
submitted to is situated within wider structures of gender inequality: femininity is 
denigrated compared to masculinity, and so trans women are typically subject to a 
higher level of scrutiny and prejudice than trans men. However, within this article I 
consider an alternative angle to this inequality: how trans men and non-binary people 
are affected by social attitudes towards bodily anatomy which is perceived as 
female. In this context, it is relevant to observe that feminist accounts of the control 
of the ‘female’ body often detail ways in which people perceived as gender non-
conforming have been forced back to the category of woman through pathologisation 
and medical intervention (Groneman, 1994; Terry, 1995). There are links between 
ways in which female bodies and trans masculine bodies have been subject to 
medical intervention, precisely because in the eyes of many, they are the same 
thing. 
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In addressing this issue as a feminist issue, I recognise that there are gendered 
structures of oppression with direct, material consequences, which result from 
expecting people to conform to binary categories and privileging that which is 
categorised as male over that which is considered female. Accordingly, within this 
article, I describe the reproductive system which consists of womb, ovaries, fallopian 
tubes and vagina as being anatomy which is typically seen as female. However, my 
acknowledgement that certain types of anatomy are socially perceived as female is 
not intended to deny or undermine the gendered experiences of trans masculine 
people, and the ways in which they understand their own bodies.  
Taking a feminist stance in this article also allows me to engage with an 
epistemological dilemma. Trans masculine hysterectomies are rarely discussed in 
academic literature (Colebunders et al., 2016; Rachlin, Hansbury, & Pardo, 2010). 
But I am a trans man, who has belongs to trans masculine communities for over a 
decade. I got advice from friends about my own hysterectomy, and I have given 
advice to others. There is an academic convention that there is no need to cite what 
is common knowledge. However, my own ‘common knowledge’ about trans 
masculine hysterectomy is almost entirely missing from the academic literature. 
Feminist scholarship has often explicitly recognised the value of experiential 
knowledge, especially where certain types of knowledge has been systematically 
excluded, or rendered untellable in frameworks of analysis which do not address 
intersections of marginalisation (Crenshaw, 1991; Letherby, 2003; Stanley & Wise, 
1993). Hence, while this account primarily aims to analyse and critique public 
discourses on trans masculine hysterectomy, in places I signal that my own 
experiential knowledge indicates that the public discourse may be incomplete. I 
therefore explore this subject through an analytic autoethnographic approach, in 
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which I critically analyse how the social world which I am a member of is affected by 
medical practices, legal constraint, and social discourse (Anderson, 2006) 
The medical case for the ‘risky’ trans masculine womb 
Recommendations regarding hysterectomies are often focused upon risks believed 
to derive from testosterone therapy. The NHS England (2013:17) protocol for treating 
trans people states: “Continuous use of testosterone therapy in trans-men with an 
intact uterus increases their risk of developing endometrial hyperplasia and 
malignancy. Trans-men should be informed of this before commencing testosterone 
therapy and be strongly recommended to have a hysterectomy and bilateral 
salpingo-oophorectomy after receiving continuous testosterone therapy for 2-5 
years.” Similarly, guidance from the endocrinologist at Charing Cross Gender Identity 
Clinic, the largest in the UK, states: “We also normally recommend hysterectomy 
after 2 years of treatment to prevent any risk of problems in the womb occurring.” 
(Seal, undated). Neither of these documents provide further references. 
In contrast, the Standards of Care issued by the World Professional Association for 
Transgender Health (WPATH) discusses the potential side effects from 
masculinising hormone therapy, and categorises ovarian, uterine [endometrial] and 
cervical cancer as “no increased risk or inconclusive” (Coleman et al., 2012). Wesp 
(2017), reviewing the literature, concludes that while there is a hypothetical basis for 
positing an increased risk to trans masculine people of endometrial hyperplasia or 
cancer, only one such case has been documented. She adds that there is also no 
evidence that trans masculine people are at increased risk of ovarian cancer. Wesp 
(2017) therefore concludes that hysterectomy should not be recommended purely for 
prevention of either uterine or ovarian cancer. Feldman (2016) reaches broadly 
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similar conclusions, and additionally notes that there is no evidence that testosterone 
affects the risk of cervical cancer. However Feldman (2016) does offer a low-grade 
recommendation that oophorectomy and/or hysterectomy be considered where there 
are particular concerns about ovarian, cervical or uterine cancer, especially if the 
patient is older, not concerned about fertility, unwilling to undergo screening, and 
surgery would not pose a health risk. 
Feldman’s reference to age is particularly significant. Demographic data on trans 
populations is poor, and subject to methodological variation. However, gender clinics 
within Europe typically report that the majority of their trans masculine patients seek 
and receive treatment before they are thirty (De Cuypere et al., 2007; Dhejne, 
Öberg, Arver, & Landén, 2014; Gómez-Gil, Trilla, Salamero, Godás, & Valdés, 2009; 
Kreukels et al., 2012; Simonsen, Hald, Giraldi, & Kristensen, 2015). Recent UK data 
suggests that trans masculine people make up two-thirds of referrals to gender 
clinics for those under 18, but only a small fraction of referrals over the age of 65 
(Bouman et al., 2016; Tavistock and Portman Gender Identity Service, 2016). It 
therefore appears that the NHS England (2013) recommendation to undertake 
hysterectomy two to five years after commencing testosterone would largely apply to 
patients aged in their twenties or thirties. However, endometrial cancer is primarily 
diagnosed in those aged over 65, and is rare in young adults, with only 18 cases of 
endometrial cancer diagnosed among people under the age of 30 in the UK each 
year (Cancer Research UK, 2016c). Even if there was overwhelming evidence that 
testosterone substantially increased the risk of endometrial cancer (which at present 
there is not), it seems questionable whether this baseline rate of incidence is 
sufficient to justify recommending hysterectomy for trans masculine people still in 
their twenties. 
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Cervical and ovarian cancer are not cited in the NHS England guidance, but could 
also be considerations in surgical intervention. Historically, trans masculine people 
were believed to be at a heightened risk of ovarian cancer, on the somewhat 
tenuous basis of an observation that the ovaries of trans masculine people appeared 
to resemble those patients with polycystic ovary syndrome (PCOS) ovaries, and 
PCOS was potentially linked with cancer (Feldman, 2016; Mueller & Gooren, 2008; 
Wesp, 2017).  This has now been disrupted on the dual grounds that trans 
masculine ovaries are no longer thought to resemble those of PCOS-sufferers, and 
PCOS is not conclusively associated with ovarian cancer (Feldman, 2016; Mueller & 
Gooren, 2008; Wesp, 2017). Ovarian cancer, although most common in older adults, 
does occur among young people in their twenties and thirties (Cancer Research UK, 
2016b). Cervical cancer also occurs relatively commonly among younger adults 
(Cancer Research UK, 2016a). Evidence from outside the UK  suggests that trans 
masculine people are less likely to have smear tests, and more likely to have 
inconclusive results (Feldman, 2016; Hsiao, 2017; Peitzmeier, Reisner, Harigopal, & 
Potter, 2014). However, some trans masculine people may have a relatively low risk 
of cervical cancer, for example if they have never been exposed to the HPV virus 
(Feldman, 2016). A HPV vaccine programme was introduced in the UK in 2008, 
which is likely to mean that current and future cohorts of young trans masculine 
people will have a reduced risk of cervical cancer (Cuzick, Castãón, & Sasieni, 2010; 
Mesher et al., 2013). Although trans masculine people can be affected by ovarian 
and cervical cancer, there does not appear to be strong evidence that trans 
masculine people are inherently at greater risk than other groups. Insofar as there is 
an increased risk, this may be largely due to structural factors, such as poor access 
to inclusive and affirmative gynaecological care (Peitzmeier et al., 2014). Potential 
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unwillingness to undergo smear tests, or poor access to gynaecological care are not 
normally considered justifications for a hysterectomy. Ovarian and cervical cancers 
are not cited by NHS England (2013) in justifying its current policy on hysterectomy 
and salpingo-oopherectomy, and Feldman (2016) does not conclude that these 
issues necessitate prophylactic surgery.  
The current guidelines therefore justify surgery in terms of a ‘risk’ which is largely 
unsupported by evidence. This is despite the fact that the practice of trans 
healthcare otherwise errs towards non-intervention. Hysterectomy with salpingo-
oopherectomy is a significant medical procedure with irreversible consequences, 
most notably for fertility. In addition, the surgery carries some risk of complications, 
although data on complications in trans masculine people is limited (Colebunders et 
al., 2016; Rachlin et al., 2010). The structure of gender identity services may be one 
factor in the emphasis on ‘risks’ which are in fact minimal in younger people. The 
pathway of care is designed on the basis of all treatments taking place within a 
concurrent period of time, with the patient discharged at the end (NHS England, 
2013). Accordingly, the pathway does not facilitate a twenty year-old transitioning, 
deciding to retain his womb and ovaries for now, and reconsider the risks when he is 
in his forties. However, this structural issue does not seem to be enough on its own 
to account for the strong assertion of risk based upon little evidence. 
Other medical factors promoting surgery 
‘Risk’ is the formal reason given in the UK for recommending hysterectomy for trans 
masculine people. However, it is not the only reason why trans masculine people 
decide to undergo this procedure. For some, knowing that they have a womb and 
ovaries is part of a sense of distress (‘dysphoria’) with their anatomy, and hence 
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removal of these organs is an important part of their transition (Rachlin et al., 2010). 
It has also been suggested that a hysterectomy and salpingo-oopherectomy may 
allow trans masculine people to reduce the amount of testosterone they need to 
take, although the evidence is poor (GIRES, 2008; Rachlin et al., 2010). My own 
perception from talking to trans masculine people is that other physiological 
problems such as pain, cramping or bleeding is often a catalyst for deciding to 
proceed with hysterectomy. However, these issues are poorly documented in the 
literature, with the exception of Rachlin et al. (2010). It is unclear how common such 
problems are, and whether surgery is the only solution. 
Rachlin et al. (2010) appear to have conducted the only recent piece of research 
addressing the question of why trans masculine people undergo hysterectomy and 
salpingo-oopherectomy. They use a convenience sample of 134 trans masculine 
people, apparently mostly but not exclusively from the US. Participants could cite 
multiple reasons for undergoing hysterectomy and salpingo-oopherectomy, and were 
also asked to rank them. Overall, the five most important factors were preventative 
healthcare; feelings of gender incongruence; resolution of other medical problems; 
requirements relating to legal recognition; and to stop extreme bleeding and 
cramping. A number of other physiological and social factors were also cited. The 
study also highlights the impact of surgery. Although few participants experienced 
regrets, and none entirely regretted their decision to have surgery, a high proportion 
reported medical complications, and around half reported some degree of change in 
sexual sensation or experience, although mostly for the better.  
Rachlin et. al’s (2010) findings are not necessarily transferable to a UK context. 
Some of the factors listed, such as the need for a hysterectomy in order to gain legal 
recognition, are inapplicable in the UK. In addition, many of Rachlin et. al’s (2010) 
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participants could not access state or insurance funding which fully covered the cost 
of surgery. On average, participants paid around $10,000 for hysterectomies. 
Individuals in some countries may not receive paid sick leave for transition-related 
surgeries. It seems likely that this financial burden would tend to result in a higher 
proportion of patients undergoing surgery in response to an immediate need than 
would be found in a UK sample, where state-funded surgery is available. 
Clearly there are circumstances where individuals decide to have a hysterectomy 
and salpingo-oopherectomy because their reproductive anatomy is causing them 
distress, either due to anatomic dysphoria, or due to gynaecological concerns. It is 
not my intention to suggest that trans people should not have the right to make such 
decisions. However, at present there seems to be remarkably little data as to why 
hysterectomies are being undertaken in the trans masculine population, and whether 
other alternatives could be offered in some cases.  
Placing trans masculine hysterectomy in a feminist context 
The presumption that a womb and ovaries in a trans masculine individual pose a 
risk, and that hysterectomy is an appropriate solution for various gynaecological 
problems, can be placed within a wider cultural context. The notion that reproductive 
anatomy typically seen as female is inherently risky can be traced throughout much 
of Western medical history. The ancient Greeks believed that the womb could 
wander freely through the body, causing disease (Faraone, 2011; Micale & Porter, 
1995; J.M. Ussher, 1991). The assumption that internal reproductive anatomy was 
core to women’s health – and hence that women’s illness was often located in these 
organs – underpinned the development of modern gynaecology (Moscucci, 1993; 
J.M. Ussher, 1991). Even today, it is suggested that many hysterectomies are 
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performed unnecessarily to resolve conditions which could be addressed in other 
ways (Cloutier-Steele & West, 2003; Djukic, Lekovic, Jovic, & Varjacic, 2016; 
Edozien, 2005). The description of ovarian cancer as ‘insidious’ or as a ‘silent killer’ 
has similarly focused attention on the notion that internal reproductive anatomy may 
be harbouring undetectable disease, and may have contributed to a failure to 
recognise the symptoms that do occur (Jasen, 2009). As such, there is already a 
prominent social discourse of risk related to internal reproductive anatomy. 
Associated with the history of presumed risk is a medical interventionist approach to 
‘correcting’ gender diversity. Late Victorian sexologists sought to medically classify 
and correct gender and sexual diversity in people assigned female at birth. Although 
such pathologisation was typically understood at the time as relating to lesbians, the 
concept of lesbian at the time included both gender non-conformity and physiological 
masculinisation (Groneman, 1994; Terry, 1995). Terry (1995) describes attempts to 
classify lesbians’ bodies as physiologically distinct, through looking for signs of 
physical masculinisation. Case studies described in the 1886 Psychopathia Sexualis 
as extreme cases of ‘acquired homosexuality’ in women seem to relate to 
experiences which today might be seen as trans masculine (Krafft-Ebing, 2016). 
Surgical interventions were undertaken in the assumption that they would ‘fix’ 
individuals to the category of women, including oophorectomy, hysterectomy and 
clitorectomy (Groneman, 1994; J.M. Ussher, 1991).  Today, intersex children, and 
sometimes adults, continue to be subjected to surgery in the hope of ‘fixing’ their 
identity to female, with both reproductive potential and sexual satisfaction deemed 
sacrificeable for this aim (Anderson, 2015; Carpenter, 2016; Chase, 2006).  
The threshold for intervention with regard to trans masculine bodies may have been 
set particularly low because, as I will outline in the second half of this paper, it has 
13 
 
typically been assumed that trans masculine people either cannot or will not bear 
children. Reproductive ability is closely associated with social constructions of 
whether a body should be considered female or male (Burkitt, 1999; Jane M Ussher, 
2006) As such, the combination of perceived ‘riskiness’, a desire to ‘fix’ gender and 
the perception of the trans masculine body as being either a non-reproductive female 
body, or a transgressively productive male body, together creates a context in which 
hysterectomy becomes an obvious ‘solution’. 
Medico-legal denial of the pregnant man 
A discussion about hysterectomy is inevitably also a discussion about fertility and 
reproduction. Evidence regarding the impact of testosterone on trans masculine 
fertility is limited. It seems to have been previously assumed that testosterone 
therapy would inevitably cause infertility. Thus one trans community-produced 
publication from 2005 states that after approximately two years of testosterone 
therapy, trans masculine people would become permanently infertile (Blustin, 2005). 
NHS England (2013) recommends discussion on fertility prior to hormone therapy.  
Recent publications are more equivocal, noting that data is limited but there are 
multiple documented cases of trans masculine people ceasing testosterone therapy 
and conceiving, sometimes after several years (De Sutter, 2016; Light, Obedin-
Maliver, Sevelius, & Kerns, 2014; Terrence Higgins Trust, 2012). Accidental 
pregnancy remains a potential risk for those taking testosterone (Light et al., 2014; 
Reisner, Perkovich, & Mimiaga, 2010; Terrence Higgins Trust, 2012). Undergoing 
hysterectomy and salpingo-oopherectomy therefore means that a trans masculine 
person moves from being potentially capable of bearing children to definitely being 
unable to do so. 
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Medical structures have historically drawn upon gender and sexuality stereotypes in 
order to determine which forms of trans identity should receive diagnostic 
endorsement (Califia, 1997; Davy,2011; Spade, 2006). Thus Benjamin (1966), who 
was highly influential in establishing medical criteria for transition, stated that trans 
men would be attracted to feminine women, and desperately desire to be husbands 
and fathers. Benjamin does provide an account of a trans man who became 
pregnant. However, Benjamin presents this as a strategic technique: the trans man 
did not desire to give birth, or to engage in vaginal sex, but was merely willing to 
undergo these experiences to achieve his ultimate aim of being a father. A trans 
masculine person who willingly enters into an enjoyable, sexual relationship with a 
man and/or gave birth, may therefore risk his maleness being challenged, and 
access to treatment denied. More (1998:325) quotes a trans man who states that the 
gender clinic he attended saw his engagement in vaginal sex, and his decision to 
continue with pregnancy, as an indicator that he was ‘salvageable’ as a woman. The 
assumption that gender is defined through sexual practice has therefore served to 
restrict the sexuality and self-expression of trans people. 
In several European countries, the medical discourse on hysterectomies is 
interconnected with the fact that sterilisation is a specific precondition of legal gender 
recognition: it is not legally possible for a man to be pregnant (Carastathis, 2015; 
TGEU, 2016). In the UK, the Gender Recognition Act (2004) does not require trans 
people to undergo medical treatment prior to being recognised in their new gender, 
although an explanation must be provided if no surgery has been undertaken. It is 
therefore perfectly possible for someone to receive legal recognition as a man while 
still being capable of becoming pregnant. However, UK legislation fundamentally 
fails to recognise the parental status of a pregnant man.  
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In the Gender Recognition Act (2004) parental status is excluded from gender 
recognition as follows: “The fact that a person’s gender has become the acquired 
gender under this Act does not affect the status of the person as the father or mother 
of a child.” The explanatory notes add: “This provides that though a person is 
regarded as being of the acquired gender, the person will retain their original status 
as either father or mother of a child. The continuity of parental rights and 
responsibilities is thus ensured.” The phrasing here is brief and somewhat 
ambiguous. However, the references to “original” and “continuity” in the explanatory 
notes indicate that what is being discussed is the ongoing parental status of a trans 
person regarding a child born before they received gender recognition. It is unclear 
whether these provisions are intended to apply to children born after the parent’s 
gender recognition, or indeed whether this possibility was even considered. 
Recognition of non-binary people is not granted by this legislation.  
Four years after the Gender Recognition Act, the Human Fertility and Embryology 
Act (HFEA) (2008), redefined parental categories, including greater legal recognition 
for some same-sex couples. Some aspects of this redefinition benefited some trans 
people, for example by expanding parental rights for those whose partners conceive 
through donor insemination, albeit in gendered terms. However, the HFEA 
fundamentally ignores the possibility of trans masculine pregnancy, defining the 
“mother” as the “woman” who has carried the child. The parental status of someone 
who is legally a man but carries a child is not addressed. Since non-binary gender is 
not recognised in the UK, non-binary parenthood also remains unaddressed. 
There has been greater discussion of trans fertility preservation in the medical 
literature in recent years, but primarily from a technological perspective. For trans 
masculine people, the solution which is most commonly proposed is egg freezing, 
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taking place prior to both starting testosterone and having surgery (Johnson & 
Finlayson, 2016; Richards & Seal, 2014) However, egg-freezing is not necessarily an 
ideal solution for trans masculine people wanting a family. Egg freezing is a relatively 
new technology, with limited data on outcomes (Baldwin, Culley, Hudson, & Mitchell, 
2014; Richards & Seal, 2014). Embryo freezing has a more established success 
rate, but gives a second parent rights over the embryo (Ben-Naftali & Canor, 2008; 
De Sutter, 2016; Dickens, 2016). The egg retrieval procedure may be unacceptable 
to some trans masculine people, since it involves cessation of testosterone therapy, 
commencement of oestrogen therapy and invasive gynaecological procedures 
(Armuand, Dhejne, Olofsson, & Rodriguez-Wallberg, 2017; De Sutter, 2016; 
Frederiksen, Mehlsen, Matthiesen, Zachariae, & Ingerslev, 2016; Richards & Seal, 
2014). Egg-retrieval, storage and implantation is expensive, and subject to variable 
NHS local funding policies, meaning many trans masculine people are financially 
unable to access it (Devine, 2015; Kerr, 2013; Krajewska, 2015). Finally, to actually 
use stored eggs or embryos, a surrogate is required. However, surrogacy law in the 
UK raises a number of practical barriers. For example, surrogates in the UK cannot 
be paid beyond expenses, necessitating an altruistic volunteer; the surrogate parent 
can decide not to surrender the child; and the legislation only allows for couples 
making use of surrogates, rather than single parents (Horsey, 2016; Norton, 
Crawshaw, Hudson, Culley, & Law, 2015). For many trans masculine people, egg-
freezing is therefore not a viable solution. One reason why egg-freezing may be 
championed for trans masculine people, despite its drawbacks, is that it is a process 
which removes reproduction from the body of the individual. The eggs are extracted 
in a clinic, fertilised in a laboratory and placed inside a surrogate. Society does not 
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need to publicly address the spectacle of the pregnant man, and the potential 
challenge it poses to heterosexual, binary-gendered notions of reproduction. 
Although it is recommended that fertility advice be offered to trans masculine people, 
it is unclear whether this always takes place, or the quality of such advice. In the UK, 
gender identity clinics (GICs) are predominantly staffed by mental health 
professionals (NHS England, 2015), who may lack expertise in reproductive 
medicine. In addition, GICs are commissioned nationally, with seven clinics covering 
all adults in England (NHS England, 2013). In contrast, reproductive services are 
commissioned locally, and notoriously subject to a ‘postcode lottery’ (Devine, 2015; 
Kerr, 2013; Krajewska, 2015). This may make it difficult for GICs to advise on the 
options practically available to a specific patient. General practice and local fertility 
services may also lack expertise in advising trans masculine people on fertility.  
Another factor which is typically not directly addressed in the literature is that 
reproductive technologies evolve rapidly. The first IVF baby was born less than forty 
years ago. The removal of ovaries and womb in a twenty year old not only means 
they cannot use the reproductive technologies of today, but may also limit access to 
reproductive technologies which may be available in twenty years time.  
At present, therefore, while UK legislation and medical practice does not explicitly 
prohibit male pregnancy, it tends to disregard it. Legally, there is no parental 
category covering a man or non-binary person who has given birth, and medical 
structures are not necessarily well set up for pragmatic, individualised decisions 
about fertility options.  
The social unthinkability of the pregnant man 
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Medical and legal denials of the possibility of a pregnant man occur in the context of 
broader social discourses which position male pregnancy as both novel and 
shocking. There are academic and media accounts of trans masculine pregnancy 
dating back at least to the late 1990s (Califia, 2000; Devor, 1997; Karaian, 2014; 
More, 1998). Yet in 2008, Thomas Beatie was widely described in the media as the 
world’s ‘first’ pregnant man (Currah, 2008; Jones, 2012; M. Moore, 2008). The UK 
media has announced at least two different UK ‘first’ pregnant men, one in 2012 and 
one in 2017 (Box-Turnbull, 2012; Forster, 2017; C. Moore & Dinham, 2017; Park, 
2012). The continuing sensationalised – and demonstrably false - claims of novelty 
indicates that male pregnancy currently remains outside the frame of social 
recognition. 
Trans masculine pregnancy has often been controversial even among trans people. 
Green (2004) describes hostility within the trans community to a couple who has a 
child in 1999. My own recollection is that Thomas Beattie’s pregnancy was 
commented on negatively in UK trans masculine communities in 2008. UK trans 
communities seem to me to be more supportive towards trans masculine pregnancy 
today, but there remains criticism of those who are seen as deliberately seeking 
publicity around being pregnant. This hostility seems to be underpinned by a concern 
about social validation: how can anyone take us seriously as men, if some of us get 
pregnant?  
There is justification for such concerns. Trans masculine people in the media often 
do need to explicitly confront perceptions that pregnancy invalidates expressed 
identity, and that it is simply impossible to be a pregnant man (Riggs, 2013, 2014). 
As I outlined earlier, medical assessment processes have often assumed that a ‘true’ 
trans man would never seek to become pregnant. Lesbian and gay parenting has 
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been subject to repeated scrutiny and legal restriction over concerns that traditional 
mother and father roles are required for psychological wellbeing of the child, or that 
same-gender parents may transmit homosexuality or gender non-conformity to the 
child (Clarke, 2001; Hicks, 2003, 2005). Trans masculine parenting may raise similar 
concerns, heightened by the physiological nature of transition. For example, Thomas 
Beatie was questioned about whether his exposure to testosterone could harm his 
child (Riggs, 2014). These concerns were in part offset by a medical account that 
Beatie’s testosterone levels were ‘normal’ (presumably meaning within a typical 
female range), and by Beatie’s self-presentation as a ‘normal’ man who simply 
wanted to have a family with his infertile wife (Halberstam, 2010; Riggs, 2014). 
Explicit accounts of the pregnant man as ‘normal’ may be strategically desirable 
within a social context that positions his experiences as shocking, dangerous or 
simply unthinkable. 
There is little literature discussing pregnancy or fertility among non-binary people. 
However, the widespread association of sexuality and fertility with masculinity and 
femininity may have contributed to a stereotype that non-binary people are asexual. 
Thus Barrett (2007:43) described non-binary people as being largely unable or 
unwilling to engage in interpersonal relationships. More recently, other clinicians 
have presented a rather more nuanced and inclusive view of non-binary identities, 
including highlighting the need for fertility advice (Richards et al., 2016). The broader 
lack of legal or social recognition for non-binary people may introduce particular 
challenges in having their gender identity recognised while pregnant. 
 
Conclusions 
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The UK has never specifically mandated sterilisation for trans people, but its current 
medico-legal framework encourages hysterectomy for trans masculine people, and 
discourages pregnancy. I have argued that this framework can be understood from a 
feminist perspective as being rooted within a perception that internal reproductive 
anatomy is inherently risky, and within a strong social taboo regarding male 
pregnancy. Following the ECHR ruling that state-mandated sterilisation breaches 
human rights, examining discourses and practices within the UK is timely and useful 
in order to recognise and address other constraints upon trans people’s rights to 
bodily integrity and individual decisions about fertility and family.  
For some trans masculine people, hysterectomy will be appropriate to their needs. 
Many trans masculine people struggle to access suitable gynaecological care 
(Peitzmeier et al., 2014; Rachlin et al., 2010). It is not my intention to argue that 
hysterectomy and salpingo-oopherectomy should never be performed on trans 
masculine people, nor that additional barriers should be created. However, current 
presumptions in favour of hysterectomy appear to be poorly evidenced in the 
medical literature. Guidance offered to patients needs to reflect emerging research in 
this area, and acknowledge current uncertainty about medical risk.  
The ruling that mandatory sterilisation is a breach of human rights is welcome. 
However, the UK situation demonstrates that, even in the absence of overt legal 
requirements, medical, legal and social discourses can together position trans 
masculine fertility as risky, undesirable and unrecognised. There is a danger that in 
the absence of robust critique, social stereotypes about gender, sexuality and 
parenthood may influence care and constrain patient autonomy. Feminist critiques of 
the regulation of female bodies can be expanded to offer a mechanism for analysing 
the ways in which trans masculine bodies are also regulated and medicalised. This is 
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crucial for developing new legal and medical frameworks which facilitate trans 
people’s bodily autonomy and reproductive choices.  
Trans reproduction and fertility is an emergent area of social discourse, and one 
which is embedded in normative beliefs about the interconnection of gender, sex and 
sexuality. It is only relatively recently that transfeminist thought has provided a 
challenge to medical pathologisation, and explicitly articulated trans people’s agency 
and rationality. Nonetheless, in the UK and in many other jurisdictions, medical care 
for trans people remains subject to psychological evaluation and oversight. 
Highlighting the gendered assumptions which underpin decision-making about trans 
masculine bodies, fertility and reproductions expands transfeminist debates about 
the interconnection between gender inequality and trans experience. It also has 
implications for psychological and healthcare practice in supporting trans people to 
make individualised decisions regarding bodily interventions and reproduction. 
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